(Q37143532)

18 August 2017

1 reference

title

Transforming growth factor-beta in cutaneous melanoma (English)

1 reference

18 August 2017

Delphine Javelaud

1

1 reference

18 August 2017

Vasileia-Ismini Alexaki

series ordinal

2

1 reference

18 August 2017

Alain Mauviel

series ordinal

3

1 reference

18 August 2017

publication date

1 April 2008

1 reference

Pigment Cell & Melanoma Research

18 August 2017

published in

1 reference

18 August 2017

volume

21

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

123-132

1 reference

TGF-beta antagonists: why suppress a tumor suppressor?

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00450.X

Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00450.X

Analysis of BRAF mutation in primary and metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00450.X

Determinants of BRAF mutations in primary melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00450.X

Targeting aberrant TGF-beta signaling in pre-clinical models of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2008.00450.X

10.1111/J.1755-148X.2008.00450.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference